晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02228 晶泰控股

未开盘 04-28 16:08:26

8.480

+0.020

+0.24%

最高8.590	最低8.360	成交量3,389万
今开8.580	昨收8.460	日振幅2.72%
总市值364.89亿	流通市值364.89亿	总股本43.03亿
成交额2.87亿	换手率0.79%	流通股本43.03亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股","latestPrice":8.48,"timestamp":1777363706004,"preClose":8.46,"halted":0,"volume":33890596,"delay":0,"changeRate":0.002364066193853377,"floatShares":4303000000,"shares":4303000000,"eps":0.03436907355453505,"marketStatus":"未开盘","change":0.02,"latestTime":"04-28 16:08:26","open":8.58,"high":8.59,"low":8.36,"amount":287201568,"amplitude":0.027187,"askPrice":8.48,"askSize":107000,"bidPrice":8.47,"bidSize":198000,"shortable":3,"etf":0,"ttmEps":0.03436907355453505,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777426200000},"marketStatusCode":0,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":8.46,"openAndCloseTimeList":[[1777339800000,1777348800000],[1777352400000,1777363200000]],"volumeRatio":0.409861,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02228","defaultTab":"news","newsList":[{"id":"1184562296","title":"异动解读 | 晶泰控股盘中大跌6.45%，年报利好兑现后承压，行业板块走弱","url":"https://stock-news.laohu8.com/highlight/detail?id=1184562296","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184562296?lang=zh_cn&edition=full","pubTime":"2026-04-24 09:56","pubTimestamp":1776995813,"startTime":"0","endTime":"0","summary":"晶泰控股今日盘中大跌6.45%，引起了市场的关注。消息面上，公司此前披露了年度业绩，收入同比增长逾两倍，并首次实现年度盈利。然而，股价在业绩公布后持续回落，呈现出“利好兑现”后的承压态势。同时，近期市场卖空活动活跃，空头成交金额占比较高，反映了部分资金的看空情绪。此外，从行业层面看，生命科学工具和服务板块整体表现疲软，晶泰控股在板块内领跌，行业环境的走弱也对股价构成了压力。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115956576","title":"晶泰控股（02228）2025年收入大增并实现扭亏 AI与药物研发协同驱动业务突破","url":"https://stock-news.laohu8.com/highlight/detail?id=1115956576","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115956576?lang=zh_cn&edition=full","pubTime":"2026-04-17 21:01","pubTimestamp":1776430883,"startTime":"0","endTime":"0","summary":"于截至2025年12月31日止年度，晶泰控股收入达人民币8.03亿元，较上一年度的2.66亿元同比增长逾两倍。集团年内利润成功扭转2024年亏损15.15亿元的局面，实现人民币1.35亿元的正向收益，其中归属于公司权益持有人的利润为1.24亿元。主要收入来源包括药物发现解决方案和AI for Science智能化解决方案，两大板块分别实现418.9%和62.6%的增长，为整体业绩带来显著提升。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628209458","title":"晶泰控股(02228)建议采纳一项新股份计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2628209458","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628209458?lang=zh_cn&edition=full","pubTime":"2026-04-17 20:51","pubTimestamp":1776430267,"startTime":"0","endTime":"0","summary":"智通财经APP讯，晶泰控股(02228)公布，董事会建议采纳一项新股份计划，以进一步使公司董事及雇员的长期利益与公司的长期利益保持一致，并激励彼等持续推动公司的增长及发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430189.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02228","BK1141","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627328922","title":"“AI制药第一股”晶泰科技进驻广州天河","url":"https://stock-news.laohu8.com/highlight/detail?id=2627328922","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627328922?lang=zh_cn&edition=full","pubTime":"2026-04-15 19:30","pubTimestamp":1776252617,"startTime":"0","endTime":"0","summary":"4月15日，AI制药领军企业、“AI制药第一股”晶泰科技正式进驻广州天河的广电平云广场，同时与广州数字科技集团、广东创新投资发展有限公司完成战略签约，共同推动医疗数据与垂类大模型在生物医药领域深度应用。同日，平云OPC创新社区挂牌。晶泰科技由三位麻省理工学院的物理学家于2015年创立，是全球领先的以AI与机器人自动化实验技术驱动研发创新的平台型企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604153706140328.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153706140328.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01477","ARTY","BK1191","BK1141","BK1617","AGIX","02228","BK1574","AIPO","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159698623","title":"异动解读 | 机构研报梳理AI制药核心价值，晶泰控股盘中大涨5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=1159698623","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159698623?lang=zh_cn&edition=full","pubTime":"2026-04-15 09:41","pubTimestamp":1776217282,"startTime":"0","endTime":"0","summary":"晶泰控股今日盘中大幅上涨5.48%，引起市场关注。消息面上，近期有机构发布深度研报，系统性地梳理了公司的核心价值。报告指出，晶泰控股在AI制药领域具有前瞻性布局和技术优势，其构建的“量子物理+AI+机器人实验”三位一体全链条技术闭环，以及较高的商业化项目兑现率，为公司基本面提供了有力支撑，这或是推动股价走强的主要原因。此外，公司在融资、实验效率及中长期打造AI for Science通用研发平台的目标方面表现突出，增强了市场对其未来增长潜力的信心。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626135899","title":"晶泰控股(02228)授出合共1123.43万购股权及1092.08万个受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2626135899","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626135899?lang=zh_cn&edition=full","pubTime":"2026-04-09 22:32","pubTimestamp":1775745144,"startTime":"0","endTime":"0","summary":"智通财经APP讯，晶泰控股(02228)发布公告，于2026年4月9日，本公司根据购股权计划的条款向137名承授人授出合共1123.43万购股权及根据受限制股份单位计划的条款向270名承授人授出合共1092.08万个受限制股份单位，惟各自须待接纳后方可作实。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1426793.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02228","BK1141","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106286256","title":"晶泰控股更新3月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1106286256","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106286256?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:36","pubTimestamp":1775637385,"startTime":"0","endTime":"0","summary":"晶泰控股有限公司于2026年4月8日发布2026年3月股份变动月报表，报告期截至2026年3月31日。根据公告，法定股本保持在100,000,000,000股，面值每股USD 0.00001，对应总额USD 1,000,000；已发行股份数亦维持在4,303,371,761股，无任何新增发行或回购注销情况。根据月报披露，报告期内并无股份发行、购回或库藏股变动。公司同时确认已符合香港联交所对于上市公司公众持股量的要求。公司强调将继续遵守香港联交所《上市规则》及相关法律规定，当前股本结构保持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623373124","title":"【券商聚焦】中信证券：基本医保基金收支和结余整体保持稳健","url":"https://stock-news.laohu8.com/highlight/detail?id=2623373124","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623373124?lang=zh_cn&edition=full","pubTime":"2026-03-31 08:59","pubTimestamp":1774918794,"startTime":"0","endTime":"0","summary":"2026年2月医保支出同比增速回升，收支剪刀差有所收窄。该机构预计在医保基金监管力度持续加大，DRG/DIP精细化管理的推动下，2026年全年基金结余率或将延续此前节奏略有提升。医疗健康产业政策改革进入密集期，建议持续关注政策驱动下的医疗健康产业投资机会。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977773","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0012","BK1161","LU0348735423.USD","BK1583","BK1515","IE00BPRC5H50.USD","BK0028","IE00B543WZ88.USD","BK1593","LU1303224171.USD","LU0307460666.USD","LU1969619763.USD","BK1564","01530","LU0348766576.USD","LU2148510915.USD","LU2476274308.USD","BK1617","LU2495084118.USD","03933","LU1997245177.USD","LU0405327148.USD","02367","01099","LU1719994722.HKD","BK1147","09926","LU1255011170.USD","LU1770034418.SGD","02268","09688","BK0276","BK1100","LU0634319403.HKD","LU1115378108.SGD","06160","HK0000165453.HKD","02228","LU2488822045.USD","01789","LU0348783233.USD","LU2399975544.HKD","06821","BK1588","LU1328615791.USD","600030","02196","06030","BK1191","LU0405327494.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622446802","title":"如何解读晶泰控股这份“扭亏为盈”财报？","url":"https://stock-news.laohu8.com/highlight/detail?id=2622446802","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622446802?lang=zh_cn&edition=full","pubTime":"2026-03-28 10:46","pubTimestamp":1774666016,"startTime":"0","endTime":"0","summary":"3月25日，中国AI制药“第一股”晶泰控股披露了2025年全年业绩公告，交出了一份亮眼的“扭亏”答卷。今天，我们将从纯财务视角出发，层层拆解，还原晶泰控股“扭亏为盈”的真实面貌。这笔 5100 万美元首付款，成为晶泰控股实现 “扭亏” 的重要支撑，而 4900 万美元里程碑款并未计入本次财报。02 核心主业持续向好尽管晶泰控股本次扭亏并非依靠持续经营业务驱动，但其核心业务基本面确实呈现持续向好态势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1774582771818978437","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2622281595","title":"晶泰控股2025年营收8亿：经营利润5524万 刚发行29亿港元债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2622281595","media":"雷递网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622281595?lang=zh_cn&edition=full","pubTime":"2026-03-27 09:41","pubTimestamp":1774575672,"startTime":"0","endTime":"0","summary":"晶泰控股有限公司（简称：“晶泰控股”，股票代码：“2228”）日前发布截至2025年12月31日的财报。财报显示，晶泰控股2025年营收为8亿元，较上年同期的2.66亿元增长201%。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260327/6391020126839380581981730.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260327/6391020126839380581981730.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n33072/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622285725","title":"晶泰科技2025年年报出炉：首次盈利，AI for Science进入价值兑现期","url":"https://stock-news.laohu8.com/highlight/detail?id=2622285725","media":"经济参考网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622285725?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:18","pubTimestamp":1774527517,"startTime":"0","endTime":"0","summary":"3月25日晚，晶泰控股（2228.HK）发布2025年全年业绩报告。数据显示，公司全年营收达8.03亿元，同比增加201.2%。报告期内，公司首次实现年度盈利，也成为AI应用领域率先盈利的港股上市公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603263685820583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","AGIX","BK1617","02228","CHAT","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622783996","title":"“AI制药”的晶泰控股扭亏虚与实","url":"https://stock-news.laohu8.com/highlight/detail?id=2622783996","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622783996?lang=zh_cn&edition=full","pubTime":"2026-03-26 14:52","pubTimestamp":1774507932,"startTime":"0","endTime":"0","summary":"港股“AI制药明星企业”晶泰控股交出了上市以来的首份扭亏答卷。\n2025年，晶泰控股实现营业收入8....","market":"fut","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3768447","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"“AI制药”的晶泰控股扭亏虚与实","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1617","AGIX","BK1191","CHAT","BK1141","02228","01477","AIPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173204622","title":"异动解读 | 晶泰控股盘中大涨5.18%，首次全年盈利及AI平台商业化进展提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1173204622","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173204622?lang=zh_cn&edition=full","pubTime":"2026-03-26 09:38","pubTimestamp":1774489112,"startTime":"0","endTime":"0","summary":"晶泰控股今日盘中大涨5.18%，引起了市场的广泛关注。消息面上，公司于3月25日发布了2025年年度业绩报告，首次实现全年盈利，成为AI for Science领域首家盈利的港股上市公司。同时，晶泰控股近期与DoveTree达成了一项总订单规模约470亿港元的管线合作，并获得了约4亿港元首付款，创下了人工智能新药研发领域订单规模的新纪录。公司还在大分子药物研发领域与礼来达成总额达3.45亿美元的多靶点战略合作及平台授权协议。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"e1d988722ff66852c525a3ca4fcad38d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622022284","title":"晶泰控股(02228)发布年度业绩，股东应占利润1.24亿元 同比扭亏为盈 在AI应用领域稳居行业领先地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2622022284","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622022284?lang=zh_cn&edition=full","pubTime":"2026-03-25 18:28","pubTimestamp":1774434519,"startTime":"0","endTime":"0","summary":"智通财经APP讯，晶泰控股 发布截至2025年12月31日止年度业绩，该集团取得收入人民币8.03亿元，同比增加201.25%;公司权益持有人应占年内利润人民币1.24亿元，同比扭亏为盈;每股盈利人民币3分。公告称，集团首次实现年度盈利，也成为AI for Science领域首家盈利的港股上市公司。截至2025年12月31日集团现金余额合计人民币70.69亿元，2026年集团新发可转债净额人民币25.37亿元，充沛的资金储备为持续研发投入提供硬核保障，进一步巩固晶泰在AI4S领域的行业领先地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418837.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","02228","BK1617","BK1141","BK4588","AIQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153105363","title":"晶泰控股2025年度收入大幅提升并成功扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1153105363","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153105363?lang=zh_cn&edition=full","pubTime":"2026-03-25 18:25","pubTimestamp":1774434326,"startTime":"0","endTime":"0","summary":"晶泰控股于2025年度实现收入约8.03亿元，较2024年的2.66亿元大幅增长。其中，“药物发现解决方案”板块从1.04亿元增至5.38亿元，“AI for Science智慧解决方案”则由1.63亿元上升至2.65亿元。同期营业成本为2.43亿元，研发投入亦从4.18亿元提升至5.69亿元，一般及行政开支小幅下降至4.10亿元，销售及营销开支则增至0.81亿元。综合来看，公司在2025年大幅扩张主营业务规模并实现盈利转变，整体财务状况随权益规模扩张而得到进一步增强。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621095723","title":"【券商聚焦】交银国际：CXO行情持续回暖 料板块估值倍数合理","url":"https://stock-news.laohu8.com/highlight/detail?id=2621095723","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621095723?lang=zh_cn&edition=full","pubTime":"2026-03-23 10:25","pubTimestamp":1774232735,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，多重利好因素共振下，2025年以来CXO行情持续回暖。该机构建议重点关注标的细分赛道成长力、核心能力布局、盈利和订单增长能见度、地缘风险敞口及估值上升空间。基于此，该机构首推药明合联，首次覆盖并重点推荐凯莱英和康龙化成。","market":"us","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977006","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1617","BK1197","BK1141","BK1583","BK1500","IE00B543WZ88.USD","06160","LU0417516902.SGD","LU0540923850.HKD","02228","06821","BK1574","LU1719994722.HKD","BK1585","LU1303224171.USD","BK1161","CXO","LU2488822045.USD","LU0348735423.USD","02367","LU0348766576.USD","09926","01099","LU1770034418.SGD","BK1593","01530","LU2476274720.SGD","LU2778985437.USD","09688","BK1191","BK1207","LU0348767384.USD","LU1115378108.SGD","03329","LU2328871848.SGD","LU0417516738.SGD","LU2399975544.HKD","LU0417516571.SGD","LU2476274308.USD","01789","LU0348827113.USD","LU0348784397.USD","02196","LU0634319403.HKD","02268","03933","IE00BPRC5H50.USD","BK1588","LU1794554557.SGD","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619348894","title":"港股异动 | 晶泰控股(02228)现涨超4% 2025年度首次盈利 稀缺AI制药平台价值加速兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2619348894","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619348894?lang=zh_cn&edition=full","pubTime":"2026-03-16 14:27","pubTimestamp":1773642425,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，晶泰控股现涨超4%，截至发稿，涨4%，报9.88港元，成交额3.83亿港元。消息面上，晶泰控股此前发布盈喜，预计公司2025年度实现营收不少于7.8亿元，同比增长超193%；归母净利润不少于1亿元，同比扭亏为盈，首次实现全年盈利。国联民生发布研报称，2025年业绩亮眼，稀缺AI制药平台价值加速兑现。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3923f54d12d0c12982608f5f8a99e8da","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414227.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4588","BK1191","BK1574","VXUS","01477","02228","BK1617","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618979251","title":"每日卖空追踪 | 晶泰控股 03月11日卖空量成交94.8万股，卖空比例为3.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618979251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618979251?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217829,"startTime":"0","endTime":"0","summary":"晶泰控股北京时间03月11日，跌1.2%，卖空量成交94.8万股，较上一交易日减少85.3%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163353a6b794f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163353a6b794f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1617","02228","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618979298","title":"晶泰控股03月11日主力净流出1637.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2618979298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618979298?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:16","pubTimestamp":1773216961,"startTime":"0","endTime":"0","summary":"03月11日, 晶泰控股股价跌1.20%，报收9.90元，成交金额3.0亿元，换手率0.69%，振幅2.59%，量比0.44。晶泰控股今日主力资金净流出1637.8万元，上一交易日主力净流入941.4万元。该股近5个交易日上涨3.24%，主力资金累计净流入1162.3万元；近20日主力资金累计净流出1.7亿元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162134a460ac60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311162134a460ac60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228","BK1617"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618193105","title":"晶泰控股(02228)委任周斐然为首席财务官","url":"https://stock-news.laohu8.com/highlight/detail?id=2618193105","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618193105?lang=zh_cn&edition=full","pubTime":"2026-03-10 18:54","pubTimestamp":1773140068,"startTime":"0","endTime":"0","summary":"智通财经APP讯，晶泰控股(02228)公布，周斐然先生由2026年3月10日起获委任为公司首席财务官。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02228","BK1141","BK1617"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"https://www.xtalpi.com","stockEarnings":[{"period":"1week","weight":-0.1494},{"period":"1month","weight":-0.1167},{"period":"3month","weight":-0.3178},{"period":"6month","weight":-0.2522},{"period":"1year","weight":0.666},{"period":"ytd","weight":-0.1036}],"compareEarnings":[{"period":"1week","weight":-0.0305},{"period":"1month","weight":0.0292},{"period":"3month","weight":-0.0772},{"period":"6month","weight":-0.0229},{"period":"1year","weight":0.1688},{"period":"ytd","weight":0.0019}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。该公司主要经营两个业务。药物发现解决方案业务从事就新型药物发现工作为各类生物技术与制药公司和学术机构提供模块独立解决方案或与之合作。智能自动化解决方案业务从事提供固态研发服务及自动化化学合成服务。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.06643},{"month":2,"riseRate":0.285714,"avgChangeRate":0.016028},{"month":3,"riseRate":0,"avgChangeRate":-0.069153},{"month":4,"riseRate":0.666667,"avgChangeRate":0.048494},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.010585},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.023767},{"month":7,"riseRate":0.428571,"avgChangeRate":0.047576},{"month":8,"riseRate":0.5,"avgChangeRate":-0.032189},{"month":9,"riseRate":0.8,"avgChangeRate":0.065839},{"month":10,"riseRate":0.6,"avgChangeRate":0.092453},{"month":11,"riseRate":0.5,"avgChangeRate":0.05299},{"month":12,"riseRate":0.5,"avgChangeRate":-0.011625}],"exchange":"SEHK","name":"晶泰控股","nameEN":"XTALPI"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"晶泰控股,02228,晶泰控股股票,晶泰控股股票老虎,晶泰控股股票老虎国际,晶泰控股行情,晶泰控股股票行情,晶泰控股股价,晶泰控股股市,晶泰控股股票价格,晶泰控股股票交易,晶泰控股股票购买,晶泰控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"晶泰控股(02228)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供晶泰控股(02228)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}